Debunking the Probiotic IQ Myth

Debunking the Probiotic IQ Myth

In recent years, probiotics have garnered significant attention as potential solutions for improving gut health and reducing the risk of certain diseases. But what exactly are probiotics, and do they truly live up to the hype? In this essay, we will delve into the world of probiotics, exploring how these "good bacteria" positively impact our gut health, combat harmful conditions, and promote overall well-being.

Understanding Probiotics

Before we delve into the benefits of probiotics, let's grasp a clear understanding of what they are. Probiotics are live microorganisms, often referred to as "good bacteria," that offer health benefits when consumed in adequate amounts. These beneficial bacteria occur naturally in certain foods or can be taken as supplements.

Probiotics and Disease Prevention

A. Gut Health and Inflammatory Bowel Disease (IBD)

Inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, are characterized by chronic inflammation in the digestive tract. Encouragingly, specific strains of probiotics like Lactobacillus and Bifidobacterium show promise in reducing inflammation and alleviating symptoms in individuals with IBD.

Indications of an unhealthy gut:

  • Elevated levels of inflammatory markers (1)
  • Altered gut microbiota composition (2)
  • Impaired gut barrier function (3)
  • Reduced production of short-chain fatty acids (SCFAs) (4)

Beneficial substrates produced by probiotics:

  • Short-chain fatty acids (SCFAs):

Lactobacillus and Bifidobacterium strains produce acetate, propionate, and butyrate, which support a healthy gut barrier, provide energy to colon cells, and possess anti-inflammatory properties. (5)

  • Bacteriocins:

Certain strains of Lactobacillus and Bifidobacterium produce antimicrobial compounds that inhibit the growth of harmful bacteria. (6)

  • Mucins:

Probiotic strains promote the production and secretion of mucins, which maintain a healthy gut barrier and foster interaction with beneficial bacteria. (7)

  • Antioxidants:

Select Lactobacillus and Bifidobacterium strains produce antioxidants that protect against oxidative stress and inflammation in the gut. (8)

B. Obesity and Metabolic Disorders

Imbalances in gut bacteria, associated with obesity and metabolic disorders, can contribute to weight gain and fat accumulation in the liver. Notably, probiotics like Lactobacillus gasseri and Bifidobacterium lactis have been found to reduce fat deposition, improve metabolic markers, and positively impact individuals with fatty liver disease.

Indications of an obesity-related gut:

  • Increased levels of Firmicutes bacteria (9)
  • Decreased levels of Bacteroidetes bacteria (9)
  • Altered production of short-chain fatty acids (SCFAs) (10)
  • Increased gut permeability (11)
  • Altered bile acid metabolism (12)

Beneficial substrates produced by probiotics:

  • Short-chain fatty acids (SCFAs):

Lactobacillus gasseri and Bifidobacterium lactis may promote SCFA production, enhancing energy expenditure, increasing fat oxidation, and reducing fat storage. (13)

  • Bile acid metabolism:

These probiotics can impact bile acid metabolism, influencing fat absorption and metabolism. (12)

  • Gut barrier integrity:

Lactobacillus gasseri and Bifidobacterium lactis help maintain a healthy gut barrier, preventing the entry of harmful substances and reducing inflammation. (14)

  • Regulation of appetite and satiety:

These probiotics may influence appetite-regulating hormones, contributing to better appetite regulation and weight management. (15)(16)

C. Immune Function and Allergies

Probiotics play a crucial role in modulating the immune system. Strains such as Lactobacillus rhamnosus and Bifidobacterium lactis have demonstrated the ability to reduce the risk of allergies and improve immune responses.

Indications of an Unhealthy Gut and Compromised Immunity:

  • Decreased production of short-chain fatty acids (SCFAs) (17)
  • Increased gut permeability (18)
  • Dysbiosis or imbalanced gut microbiota (19)
  • Altered production of immunomodulatory molecules (17)

Probiotics and their Impact on Immune Function:

  • Induction of cytokines:

Strains like Lactobacillus rhamnosus and Bifidobacterium lactis stimulate the production of cytokines, which play a vital role in regulating immune responses and promoting a balanced immune system. (20)

  • Enhancement of gut barrier function:

Lactobacillus rhamnosus and Bifidobacterium lactis strains strengthen the integrity of the gut barrier, preventing the translocation of harmful substances, pathogens, and allergens into the bloodstream. (21)

  • Modulation of immune cell activity:

These probiotic strains can influence the activity and function of immune cells, contributing to a more robust immune response. (22)

D. Mental Health and Mood Disorders

The emerging field of research on the gut-brain axis has shed light on the profound influence of the gut microbiota on mental health and mood disorders. Notably, probiotics such as Bifidobacterium longum and Lactobacillus helveticus have shown promising effects in positively influencing mood, reducing symptoms of anxiety and depression, and promoting overall mental well-being.

Indications of an Unhealthy Gut and Mental Health Disorders:

  • Dysbiosis or imbalanced gut microbiota (23)
  • Increased gut permeability (24)
  • Altered production of neurotransmitters and neuroactive compounds, such as dopamine. Imbalances in these neurotransmitters have been implicated in mood disorders. (25)
  • Inflammation and immune dysregulation. Inflammatory processes can disrupt normal dopamine functioning, leading to alterations in motivation, motor activity, and mood-related symptoms. (26)

Probiotics and their Impact on Mental Health:

  • Neurotransmitter modulation:

Strains like Bifidobacterium longum and Lactobacillus helveticus can influence the production and metabolism of neurotransmitters such as dopamine, which are key regulators of mood, anxiety, and stress responses. (27)

  • Gut barrier integrity and permeability:

Bifidobacterium longum and Lactobacillus helveticus have shown the potential to enhance gut barrier function, reducing the translocation of pro-inflammatory molecules that can impact mental health. (28)

Additional Beneficial Substrates Released by Probiotics

In addition to their numerous health benefits, probiotics release a range of other beneficial substrates, including:

  • Vitamin B:

Probiotic strains have the ability to produce various B vitamins, which play essential roles in energy metabolism, neurological function, and overall cellular health. (29)

  • Vitamin K:

Certain strains of Lactobacillus and Bifidobacterium can produce vitamin K, which is important for blood clotting, bone health, and cardiovascular health. (29)

  • Amino acids:

Probiotics can produce a variety of amino acids, which are the building blocks of proteins and essential for various physiological processes. (29)

  • Bacteriocins:

Antimicrobial compounds produced by certain strains of probiotics that inhibit the growth of harmful bacteria and contribute to the overall antimicrobial defense of the gut. (29)

  • Enzymes:

Probiotics can produce enzymes that aid in the digestion and breakdown of complex molecules, improving digestion and reducing symptoms like lactose intolerance. (29)

  • Immunomodulatory compounds:

Probiotic strains release various immunomodulatory compounds that interact with the immune system, helping to regulate immune responses and maintain a balanced immune function. (29)


Probiotics, the "good bacteria," have gained significant attention for their potential health benefits. Understanding the impact of probiotics on gut health, disease prevention, immune function, mental well-being, and the production of beneficial substrates provides valuable insights into their role in promoting overall wellness.


By incorporating probiotics into our diet or taking them as supplements, we can support a diverse and balanced gut microbiota, strengthen gut barrier function, modulate immune responses, and potentially reduce the risk of various conditions such as inflammatory bowel disease, obesity, allergies, and mood disorders.


However, it's important to note that not all probiotics are functioning equal. The specific strains, dosage, and duration of supplementation may vary depending on individual needs and health conditions. Consulting with a healthcare professional or a registered dietitian can help determine the most suitable probiotic regimen for optimal health benefits.

So, let's embrace the power of probiotics and unlock the potential they hold in improving our well-being. With a healthy gut, we can pave the way for a healthier, happier, and more vibrant life.



  1. Scaldaferri, F., Gerardi, V., Lopetuso, L. R., Del Zompo, F., Mangiola, F., Boškoski, I., Bruno, G., Petito, V., Laterza, L., Cammarota, G., Gaetani, E., Sgambato, A., & Gasbarrini, A. (2013). Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility. BioMed Research International, 2013, 1-9.
  2. Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences, 104(34), 13780-13785.
  3. Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014). Intestinal permeability – a new target for disease prevention and therapy. BMC Gastroenterology, 14(1).
  4. Louis, P., & Flint, H. J. (2016). Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology, 19(1), 29-41.
  5. Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S., & Flint, H. J. (2002). The microbiology of butyrate formation in the human colon. FEMS Microbiology Letters, 217(2), 133-139.
  6. Cotter, P. D., Ross, R. P., & Hill, C. (2012). Bacteriocins — a viable alternative to antibiotics? Nature Reviews Microbiology, 11(2), 95-105.
  7. Etzold, S., & Juge, N. (2014). Structural insights into bacterial recognition of intestinal mucins. Current Opinion in Structural Biology, 28, 23-31.
  8. Klinder, A., Shen, Q., Heppel, S., Lovegrove, J. A., Rowland, I., & Tuohy, K. M. (2016). Impact of increasing fruit and vegetables and flavonoid intake on the human gut microbiota. Food & Function, 7(4), 1788-1796.
  9. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444(7122), 1027-1031. doi:10.1038/nature05414. PMID: 17183312.
  10. Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332-1345.
  11. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., Waget, A., Delmée, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrières, J., Tanti, J., Gibson, G. R., Casteilla, L., … Burcelin, R. (2007). Metabolic Endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761-1772.
  12. Sayin, S., Wahlström, A., Felin, J., Jäntti, S., Marschall, H., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013). Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism, 17(2), 225-235.
  13. Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., Terasawa, K., Kashihara, D., Hirano, K., Tani, T., Takahashi, T., Miyauchi, S., Shioi, G., Inoue, H., & Tsujimoto, G. (2013). The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nature Communications, 4(1).
  14. Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., Perlemuter, G., Cassard-Doulcier, A., & Gérard, P. (2012). Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut, 62(12), 1787-1794.
  15. Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M., & Tsuchida, T. (2010). Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition, 64(6), 636-643.
  16. Yadav, H., Lee, J., Lloyd, J., Walter, P., & Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry, 288(35), 25088-25097.
  17. Belkaid, Y., & Hand, T. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121-141.
  18. Fasano, A. (2011). Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer. Physiological Reviews, 91(1), 151-175.
  19. Honda, K., & Littman, D. R. (2016). The microbiota in adaptive immune homeostasis and disease. Nature, 535(7610), 75-84.
  20. Gill, H. S., Rutherfurd, K. J., Cross, M. L., & Gopal, P. K. (2001). Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. The American Journal of Clinical Nutrition, 74(6), 833-839.
  21. Ismail, I. H., Licciardi, P. V., & Tang, M. L. (2013). Probiotic effects in allergic disease. Journal of Paediatrics and Child Health, 49(9), 709-715.
  22. Hoarau, C., Lagaraine, C., Martin, L., Velge-Roussel, F., & Lebranchu, Y. (2006). Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a toll-like receptor 2 pathway. Journal of Allergy and Clinical Immunology, 117(3), 696-702.
  23. Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., Li, L., & Ruan, B. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behavior, and Immunity, 48, 186-194.
  24. Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015). Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders. Frontiers in Cellular Neuroscience, 9.
  25. Strandwitz, P. (2018). Neurotransmitter modulation by the gut microbiota. Brain Research, 1693, 128-133.
  26. Felger, J. C., & Treadway, M. T. (2016). Inflammation effects on motivation and motor activity: Role of dopamine. Neuropsychopharmacology, 42(1), 216-241.
  27. Messaoudi, M., Violle, N., Bisson, J., Desor, D., Javelot, H., & Rougeot, C. (2011). Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticusR0052 and<i>Bifidobacterium longum</i>R0175) in healthy human volunteers. Gut Microbes, 2(4), 256-261.
  28. O'Mahony S.M., Clarke G., Borre Y.E., Dinan, T.G., & Cryan, J.F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res, 277, 32-48.
  29. Indira, M., Venkateswarulu, T. C., Abraham Peele, K., Nazneen Bobby, M., & Krupanidhi, S. (2019). Bioactive molecules of probiotic bacteria and their mechanism of action: A review. 3 Biotech, 9(8).
Back to blog

Leave a comment

Please note, comments need to be approved before they are published.